| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |